Zobrazeno 1 - 10
of 19
pro vyhledávání: '"William C. Stevenson"'
Autor:
Sushrut Patil, Julie McManus, Magdalena Plebanski, Peter Tan, Sarah Nicole Perruzza, William C Stevenson, Andrew H. Wei, Sharon Avery, Andrew Spencer, Shaun Fleming, Chindu Govindaraj
Publikováno v:
British Journal of Haematology. 169:199-210
In this Phase 1b study, the safety and tolerability of maintenance therapy, comprising lenalidomide (0-25 mg, days 5-25) in combination with azacitidine (50-75 mg/m(2) , days 1-5) every 28 d, was explored in 40 patients with acute myeloid leukaemia (
Autor:
Julia C. Iezzoni, James C. Boyd, William C. Stevenson, C. McCullough, M. Rezeig, Michael B. Ishitani, S. T. Traweek, Michael J. Gaffey, Stephen H. Caldwell, S. Khuroo, Timothy L. Pruett, M. A. Ali, N. Nezamuddin
Publikováno v:
Hepatology. 25:184-189
Eighty liver allografts were studied to determine the predictive value of intraoperative biopsies and postoperative liver function tests for the development of preservation injury (PI). Peak transaminase (aspartate transaminase [AST] and alanine tran
Autor:
Rolland C. Dickson, E E de Lange, C. McCullough, Stephen H. Caldwell, Timothy L. Pruett, William C. Stevenson, J Boyd, Michael B. Ishitani, Michael J. Gaffey, Carolyn Driscoll, M. Sue
Publikováno v:
Liver Transplantation and Surgery. 2:438-442
Measurement of liver volume in patients with advanced liver disease is used to gauge the appropriate size of donor organs and may have prognostic value. We sought to determine the accuracy of magnetic resonance imaging (MRI) in measuring liver volume
Autor:
R. McGory, Stephen H. Caldwell, Rolland C. Dickson, William C. Stevenson, Michael B. Ishitani, Timothy L. Pruett, Christopher McCullough, Walter Oliveira
Publikováno v:
Transplantation. 61:1358-1364
Passive immunization with hepatitis B surface antibody (anti-HBs) is important to prevent hepatitis B virus (HBV) recurrence after orthotopic liver transplantation for chronic HBV cirrhosis. Hepatitis B immune globulin (HBIG) dosing regimens have bee
Autor:
Peter I. Lobo, Christopher McCullough, William C. Stevenson, N. Nezamuddin, Felipe G. Porres, Timothy L. Pruett
Publikováno v:
Transplant International. 9:164-167
Currently there is a paucity of data regarding the influence of high serum triglyceride levels on cyclosporin A (CyA) levels and dosing. We therefore undertook a retrospective study to determine the relationship of serum lipid levels to CyA levels an
Autor:
Rolland C. Dickson, Carolyn Driscoll, M. Sue, Michael B. Ishitani, William C. Stevenson, Stephen H. Caldwell, James Bowden, Mark A. Lovell, Christopher McCullough, Timothy L. Pruett, Paul Yeaton
Publikováno v:
Liver Transplantation and Surgery. 2:124-129
Recurrence of hepatitis C virus (HCV) after liver transplantation is common and is associated with high blood levels of HCV RNA. Higher blood levels of HCV may promote body fluid expression of the virus. We tested 152 body fluid specimens from 33 pat
Autor:
Rolland C. Dickson, Stephen H. Caldwell, Carolyn Driscoll, William C. Stevenson, Michael B. Ishitani, Johnson Y.N. Lau, Christopher McCullough, Timothy L. Pruett
Publikováno v:
Transplantation. 61:701-705
Hepatitis C viral recurrence after orthotopic liver transplantation is almost universal. Hepatitis C-induced graft failure may occur, but the clinical and histologic profiles are not well defined. The aim of this study was to describe the pattern of
Publikováno v:
The American Journal of Surgery. 171:113-117
Background Lazaroids are potent inhibitors of lipid peroxidation. Whether the compounds can benefit the liver procured from non-heart-beating donors (NHBDs) is unknown. Methods Donor rats were pretreated with lazaroid U74006F (4.5 mg/kg) 1 hour befor
Publikováno v:
Transplantation. 59:357-360
The current prospective investigation was conducted to determine whether development of IgG donor-specific lymphocytotoxins detected at the onset of acute rejections was predictive of a poor-prognosis acute rejection. Between January 1990 and August
Publikováno v:
Transplantation. 55:1063-1066
Recent reports indicate a higher incidence of both acute and chronic liver allograft rejection when, at the time of transplantation, the recipients serum contains donor-specific anti-HLA antibodies. From 9/89 to 5/91, 133 liver allografts were perfor